Results 91 to 100 of about 3,286,893 (204)

Long-term safety and effectiveness of a continuous erythropoietin receptor activator (CERA) in patients with renal anemia: a prospective, observational, multicenter study

Renal Replacement Therapy, 2019
Background This observational study investigated the safety and effectiveness of continuous erythropoietin receptor activator in patients with renal anemia in Japan. Methods Patients were enrolled between August 2011 and November 2015 and followed for up
Hidehiro Tabata, Hiroyuki Kanno, Ayako Murayama, Tadashi Ishii, Ryosuke Harada, Yukio Udagawa   +5 more
doaj   +1 more source

Microfluidic Nano‐Assembly of Red‐Blood‐Cell (RBC) Lipids and Components for Engineering Extracellular Vesicles

Advanced Healthcare Materials, EarlyView.
Engineered red blood cell‐derived extracellular vesicles (eRBCEVs) are synthesized via controlled microfluidic assembly from native RBC lipids, enabling tunable encapsulation of proteins, nucleic acids, nanoparticles, and viral vectors. The platform demonstrates reproducible nanoscale architecture, preserved membrane composition, and functional cargo ...
Chiranth K. Nagaraj, Xilal Y. Rima, Kim T. Nguyen, Courtney Culkins, Nana Boateng, Jacob Doon‐Ralls, Alejandro Bresolin, Xin Huang, Hong Li, Vahedi Amid, Ajeet Pal Singh, Dharti Shantaram, Anastasiia Amari, Mangesh D. Hade, Nicholas R. Merriam, Zachary D. Schultz, Scott Q. Harper, Nizar Y. Saad, Setty M. Magaña, Willa A. Hsueh, Rachel E. Kopec, Blaise R. Kimmel, Andre F. Palmer, Eduardo Reátegui   +23 more
wiley   +1 more source

POS-762 IgA NEPHROPATHY IN KIDNEY TRANSPLANT RECIPIENTS: ONE CENTER EXPERIENCE

Kidney International Reports, 2021
N. RAPETSKAYA, K. Komissarov, A. Kalachyk   +2 more
doaj   +1 more source

Effect of right ventricular dysfunction on mortality in patients undergoing maintenance hemodialysis: a retrospective cohort study

Renal Replacement Therapy
Background Cardiovascular disease (CVD) is a major complication in patients on maintenance hemodialysis (MHD). While the effect of left ventricular dysfunction on patients on MHD is well known, the association between right ventricular (RV) dysfunction ...
Hiroki Nobayashi, Harui Bamba, Tomomichi Iida, Ryuji Aoyagi, Yukio Maruyama, Takashi Yokoo   +5 more
doaj   +1 more source

Annual Dialysis Data Report 2015, JSDT Renal Data Registry

Renal Replacement Therapy, 2018
s ᅟ The annual survey of Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) was conducted for 4380 dialysis facilities at the end of 2015, among which 4321 facilities (98.7%) responded.
Ikuto Masakane, Masatomo Taniguchi, Shigeru Nakai, Kenji Tsuchida, Shunsuke Goto, Atsushi Wada, Satoshi Ogata, Takeshi Hasegawa, Takayuki Hamano, Norio Hanafusa, Junichi Hoshino, Jun Minakuchi, Hidetomo Nakamoto, on behalf of the Japanese Society for Dialysis Therapy Renal Data Registry Committee   +13 more
doaj   +1 more source

From Cell‐Derived Vesicles to Hybrid Nanovectors: Biological Membranes as Functional Blueprints for Gene Delivery

Advanced Healthcare Materials, EarlyView.
Biologically derived and hybrid nonviral nanovectors are examined as distinct but convergent design approaches. Integrating synthetic components with biologically functionalized membranes allows efficient interactions with complex cellular environments.
Clara Baldari, Claudia Leone, Gabriella Leccese, Claudia De Stradis, Alessandra Invidia, Concetta Quintarelli, Biagio De Angelis, Franco Locatelli, Giuseppe Gigli, Gabriele Maiorano, Ilaria Elena Palamà   +10 more
wiley   +1 more source

Retroperitoneal leakage causing ultrafiltration failure during continuous ambulatory peritoneal dialysis: a case report and literature review

Renal Replacement Therapy
Background Peritoneal dialysis (PD) is associated with various complications, and the leakage of dialysate can lead to the discontinuation of PD. Retroperitoneal leakage (RPL) can be diagnosed on the basis of dialysate leakage, and, because there are few
Rina Tamai, Makoto Ochi, Yoshino Hiraaki, Yukinori Toyoshima, Daisuke Sumitani, Masayuki Shishida, Masatsugu Yano, Hiroaki Oda, Hideki Ohdan   +8 more
doaj   +1 more source

Nalfurafine hydrochloride for refractory pruritus in peritoneal dialysis patients: a phase III, multi-institutional, non-controlled, open-label trial

Renal Replacement Therapy, 2017
Background Nalfurafine hydrochloride (“nalfurafine”), the world’s first selective oral κ-receptor agonist for improving pruritus, is approved in Japan for the treatment of pruritus resistant to existing treatments in hemodialysis (HD) or chronic liver ...
Hidetomo Nakamoto, Takanori Oh, Masahiro Shimamura, Eiji Iida, Sadanobu Moritake   +4 more
doaj   +1 more source

Engineered Nanoplatforms Targeting Activated Hepatic Stellate Cells for Liver Fibrosis Therapy via TGF‐β Axis Inhibition and Ferroptosis Induction

Advanced Healthcare Materials, EarlyView.
FeS‐VA@lanifibranor (FVL), an activated hepatic stellate cell (aHSC)‐targeted nanoplatform comprising vitamin A‐functionalized two‐dimensional iron sulfide nanosheets and lanifibranor, is engineered for precision therapy of liver fibrosis. FVL suppresses the TGF‐β signaling pathway by inhibiting SMAD2/3 phosphorylation and induces ferroptosis in aHSCs,
Yinuo Yang, Mengyao Mu, Ke Ren, Hui Liu, Pengju Ma, Yingqi Wang, Mengmeng Zhang, Xueli Xu, Wenzhe Li, Wenshuang Gao, Xiao Sun, Qiang Zhu   +11 more
wiley   +1 more source

Successful autologous blood pleurodesis in two maintenance hemodialysis patients with idiopathic refractory pleural effusion: case reports and literature review

Renal Replacement Therapy
Background Refractory pleural effusion occasionally occurs in patients undergoing maintenance hemodialysis and is associated with a poor prognosis. We recently encountered idiopathic refractory pleural effusion in two patients undergoing maintenance ...
Ryoichi Miyazaki, Kyoko Miyagi, Tatsuhito Miyanaga, Kazuhiko Igarashi, Mitsuo Awaji   +4 more
doaj   +1 more source